NPS Pharma (NPSP) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	65.57M
Marketable investment securities	98.63M
Restricted cash and cash equivalents
Accounts receivable	48.85M
Prepaid expenses	5.23M
Other current assets	1.36M
Total current assets	256.45M
Equipment, net	5.79M
Goodwill	9.43M
Debt issuance costs, net
Other assets	201K
Total assets	289.62M
Accounts payable and accrued expenses
Current portion of non-recourse debt	10.25M
Total current liabilities	55.63M
Convertible notes payable
Non-recourse debt, less current portion	89.75M
Other liabilities	10.41M
Total liabilities	155.79M
Commitments and contingencies (notes 6, 8 and 9)	0
Preferred stock, $0.001 par value. Authorized 5,000,000 shares; issued and outstanding no shares	0
Common stock, $0.001 par value. Authorized 175,000,000 shares and 105,000,000 shares; issued and outstanding 86,037,694 shares and 66,986,940 shares, respectively	107K
Additional paid-in capital	1.17B
Accumulated other comprehensive income	-2.27M
Accumulated deficit	-1.03B
Total stockholders' deficit	133.83M
Total liabilities and stockholders' deficit	289.62M

Entities mentioned with NPSP

View All Entities